Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)

Introduction: Ischemic heart disease (IHD) remains the leading cause of death both in Europe and in Russia. The most common form of IHD is stable angina. There is compelling evidence that strict adherence to clinical guidelines greatly contributes to mortality reduction. However, the gap between mod...

Full description

Bibliographic Details
Main Authors: Kristina Tsukanova, Sergey Fitilev, Alexandr Vozzhaev, Irina Shkrebneva, Dmitry Klyuev
Format: Article
Language:English
Published: Belgorod National Research University 2018-06-01
Series:Research Results in Pharmacology
Online Access:https://rrpharmacology.pensoft.net/article/27709/download/pdf/
_version_ 1827613952523108352
author Kristina Tsukanova
Sergey Fitilev
Alexandr Vozzhaev
Irina Shkrebneva
Dmitry Klyuev
author_facet Kristina Tsukanova
Sergey Fitilev
Alexandr Vozzhaev
Irina Shkrebneva
Dmitry Klyuev
author_sort Kristina Tsukanova
collection DOAJ
description Introduction: Ischemic heart disease (IHD) remains the leading cause of death both in Europe and in Russia. The most common form of IHD is stable angina. There is compelling evidence that strict adherence to clinical guidelines greatly contributes to mortality reduction. However, the gap between modern knowledge and use of guideline-recommended medications remains significant. As shown by Western practice, one of the possible solutions of this problem is regular conduction of pharmacoepidemiological studies. Objective: Investigate the dynamics of drug prescription rates in patients with stable angina over the five-year period on the example of routine clinical practice of outpatient cardiology institution of Moscow for the purpose of further eliminating the prescribing gap for guideline recommended pharmacological strategies. Materials and methods: Our research work was performed as a retrospective pharmacoepidemiological study including two stages with five-year interval using cross-section method. Results and discussion: We found a significant increase in use of antiplatelets (82.7 vs. 56.2%, p<0.05) and statins (45.6 vs. 16.1%, p<0.05). Despite the unchanged use of ACE inhibitors, the prescription rate of angiotensin receptor blockers II increased (14.7 vs. 9.7%, p<0.05). Analysis of anti-ischemic pharmacotherapy revealed an increase in beta-adrenoblockers use (74.3 vs. 63.6%, р<0.05) and a decrease in use of long-acting nitrates (26.3 vs. 31.1%, р<0.05) and calcium channel blockers (35.7 vs. 39.6%, р<0.05). Significant changes were found in prescription rates and dosage regimens of single medications in each pharmacological group. The study results demonstrated an increase in frequency of capturing data on lipid profile and diet recommendations in patient records. Conclusion: Such type of pharmacoepidemiological study carried out for the first time made it possible to investigate the dynamics of specialists’ adherence to guidelines of stable angina pharmacotherapy in routine outpatient clinical practice.
first_indexed 2024-03-09T08:47:57Z
format Article
id doaj.art-8b26377715584cf09ca24df04268ea58
institution Directory Open Access Journal
issn 2658-381X
language English
last_indexed 2024-03-09T08:47:57Z
publishDate 2018-06-01
publisher Belgorod National Research University
record_format Article
series Research Results in Pharmacology
spelling doaj.art-8b26377715584cf09ca24df04268ea582023-12-02T15:02:21ZengBelgorod National Research UniversityResearch Results in Pharmacology2658-381X2018-06-0142475810.3897/rrpharmacology.4.2770927709Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)Kristina Tsukanova0Sergey Fitilev1Alexandr Vozzhaev2Irina Shkrebneva3Dmitry Klyuev4RUDN UniversityRUDN UniversityRUDN UniversityRUDN UniversityRUDN UniversityIntroduction: Ischemic heart disease (IHD) remains the leading cause of death both in Europe and in Russia. The most common form of IHD is stable angina. There is compelling evidence that strict adherence to clinical guidelines greatly contributes to mortality reduction. However, the gap between modern knowledge and use of guideline-recommended medications remains significant. As shown by Western practice, one of the possible solutions of this problem is regular conduction of pharmacoepidemiological studies. Objective: Investigate the dynamics of drug prescription rates in patients with stable angina over the five-year period on the example of routine clinical practice of outpatient cardiology institution of Moscow for the purpose of further eliminating the prescribing gap for guideline recommended pharmacological strategies. Materials and methods: Our research work was performed as a retrospective pharmacoepidemiological study including two stages with five-year interval using cross-section method. Results and discussion: We found a significant increase in use of antiplatelets (82.7 vs. 56.2%, p<0.05) and statins (45.6 vs. 16.1%, p<0.05). Despite the unchanged use of ACE inhibitors, the prescription rate of angiotensin receptor blockers II increased (14.7 vs. 9.7%, p<0.05). Analysis of anti-ischemic pharmacotherapy revealed an increase in beta-adrenoblockers use (74.3 vs. 63.6%, р<0.05) and a decrease in use of long-acting nitrates (26.3 vs. 31.1%, р<0.05) and calcium channel blockers (35.7 vs. 39.6%, р<0.05). Significant changes were found in prescription rates and dosage regimens of single medications in each pharmacological group. The study results demonstrated an increase in frequency of capturing data on lipid profile and diet recommendations in patient records. Conclusion: Such type of pharmacoepidemiological study carried out for the first time made it possible to investigate the dynamics of specialists’ adherence to guidelines of stable angina pharmacotherapy in routine outpatient clinical practice.https://rrpharmacology.pensoft.net/article/27709/download/pdf/
spellingShingle Kristina Tsukanova
Sergey Fitilev
Alexandr Vozzhaev
Irina Shkrebneva
Dmitry Klyuev
Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)
Research Results in Pharmacology
title Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)
title_full Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)
title_fullStr Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)
title_full_unstemmed Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)
title_short Analysis of changes in pharmacotherapy of stable angina over the five-year period at specialized out-patient level of medical care (pharmacoepidemiological study)
title_sort analysis of changes in pharmacotherapy of stable angina over the five year period at specialized out patient level of medical care pharmacoepidemiological study
url https://rrpharmacology.pensoft.net/article/27709/download/pdf/
work_keys_str_mv AT kristinatsukanova analysisofchangesinpharmacotherapyofstableanginaoverthefiveyearperiodatspecializedoutpatientlevelofmedicalcarepharmacoepidemiologicalstudy
AT sergeyfitilev analysisofchangesinpharmacotherapyofstableanginaoverthefiveyearperiodatspecializedoutpatientlevelofmedicalcarepharmacoepidemiologicalstudy
AT alexandrvozzhaev analysisofchangesinpharmacotherapyofstableanginaoverthefiveyearperiodatspecializedoutpatientlevelofmedicalcarepharmacoepidemiologicalstudy
AT irinashkrebneva analysisofchangesinpharmacotherapyofstableanginaoverthefiveyearperiodatspecializedoutpatientlevelofmedicalcarepharmacoepidemiologicalstudy
AT dmitryklyuev analysisofchangesinpharmacotherapyofstableanginaoverthefiveyearperiodatspecializedoutpatientlevelofmedicalcarepharmacoepidemiologicalstudy